Mikhaylov G - Search Results

1

Theranostic Applications of an Ultra-Sensitive T₁ and T₂ Magnetic Resonance Contrast Agent Based on Cobalt Ferrite Spinel Nanoparticles.

Mikhaylov G, Mikac U, Butinar M, Turk V, Turk B, Psakhie S, Vasiljeva O. Mikhaylov G, et al. Cancers (Basel). 2022 Aug 20;14(16):4026. doi: 10.3390/cancers14164026. Cancers (Basel). 2022. PMID: 36011020 Free PMC article.

2

Ferri-liposomes as an MRI-visible drug-delivery system for targeting tumours and their microenvironment.

Mikhaylov G, Mikac U, Magaeva AA, Itin VI, Naiden EP, Psakhye I, Babes L, Reinheckel T, Peters C, Zeiser R, Bogyo M, Turk V, Psakhye SG, Turk B, Vasiljeva O. Mikhaylov G, et al. Nat Nanotechnol. 2011 Aug 7;6(9):594-602. doi: 10.1038/nnano.2011.112. Nat Nanotechnol. 2011. PMID: 21822252

3

Promising approaches in using magnetic nanoparticles in oncology.

Mikhaylov G, Vasiljeva O. Mikhaylov G, et al. Biol Chem. 2011 Nov;392(11):955-60. doi: 10.1515/BC.2011.185. Biol Chem. 2011. PMID: 21848508 Review.

4

Selective targeting of tumor and stromal cells by a nanocarrier system displaying lipidated cathepsin B inhibitor.

Mikhaylov G, Klimpel D, Schaschke N, Mikac U, Vizovisek M, Fonovic M, Turk V, Turk B, Vasiljeva O. Mikhaylov G, et al. Angew Chem Int Ed Engl. 2014 Sep 15;53(38):10077-81. doi: 10.1002/anie.201402305. Epub 2014 Jun 27. Angew Chem Int Ed Engl. 2014. PMID: 24975267 Free PMC article.

5

A role for stefin B (cystatin B) in inflammation and endotoxemia.

Maher K, Jerič Kokelj B, Butinar M, Mikhaylov G, Manček-Keber M, Stoka V, Vasiljeva O, Turk B, Grigoryev SA, Kopitar-Jerala N. Maher K, et al. Among authors: mikhaylov g. J Biol Chem. 2014 Nov 14;289(46):31736-31750. doi: 10.1074/jbc.M114.609396. Epub 2014 Oct 6. J Biol Chem. 2014. PMID: 25288807 Free PMC article.

6

Crumpled Aluminum Hydroxide Nanostructures as a Microenvironment Dysregulation Agent for Cancer Treatment.

Lerner MI, Mikhaylov G, Tsukanov AA, Lozhkomoev AS, Gutmanas E, Gotman I, Bratovs A, Turk V, Turk B, Psakhye SG, Vasiljeva O. Lerner MI, et al. Among authors: mikhaylov g. Nano Lett. 2018 Sep 12;18(9):5401-5410. doi: 10.1021/acs.nanolett.8b01592. Epub 2018 Aug 2. Nano Lett. 2018. PMID: 30070485

7

Stefin A-functionalized liposomes as a system for cathepsins S and L-targeted drug delivery.

Bratovš A, Kramer L, Mikhaylov G, Vasiljeva O, Turk B. Bratovš A, et al. Among authors: mikhaylov g. Biochimie. 2019 Nov;166:94-102. doi: 10.1016/j.biochi.2019.05.018. Epub 2019 Jun 1. Biochimie. 2019. PMID: 31163196

8

Cysteine cathepsins as therapeutic targets in inflammatory diseases.

Vizovišek M, Vidak E, Javoršek U, Mikhaylov G, Bratovš A, Turk B. Vizovišek M, et al. Among authors: mikhaylov g. Expert Opin Ther Targets. 2020 Jun;24(6):573-588. doi: 10.1080/14728222.2020.1746765. Epub 2020 Apr 6. Expert Opin Ther Targets. 2020. PMID: 32228244 Review.

9

Evaluation of novel cathepsin-X inhibitors in vitro and in vivo and their ability to improve cathepsin-B-directed antitumor therapy.

Mitrović A, Završnik J, Mikhaylov G, Knez D, Pečar Fonović U, Matjan Štefin P, Butinar M, Gobec S, Turk B, Kos J. Mitrović A, et al. Among authors: mikhaylov g. Cell Mol Life Sci. 2022 Jan 6;79(1):34. doi: 10.1007/s00018-021-04117-w. Cell Mol Life Sci. 2022. PMID: 34989869 Free PMC article.

10

A New Cathepsin D Targeting Drug Delivery System Based on Immunoliposomes Functionalized with Lipidated Pepstatin A.

Kozak A, Mikhaylov G, Khodakivskyi P, Goun E, Turk B, Vasiljeva O. Kozak A, et al. Among authors: mikhaylov g. Pharmaceutics. 2023 Oct 14;15(10):2464. doi: 10.3390/pharmaceutics15102464. Pharmaceutics. 2023. PMID: 37896224 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters